Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer [NA]
This clinical trial update describes a study evaluating GAAD score plus AFP/PIVKA-II or ultrasound for surveillance of people at risk for he…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients [NA]
A randomized controlled trial evaluating bariatric surgery as a treatment for severe nonalcoholic steatohepatitis with advanced liver fibros…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis [NA]
This clinical trial evaluates whether Babao Dan Capsule in combination with antiviral therapy can reduce the incidence of hepatocellular car…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement
An ongoing clinical trial assessing systemic and portal hemostasis in patients undergoing transjugular intrahepatic portosystemic shunt plac…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis [NA]
This clinical trial is evaluating the safety and efficacy of a ketogenic diet to promote weight loss in obese adults with compensated nonalc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH) [Phase 2]
Phase 2 clinical trial to assess tolerability of BI 3802876 in adults with compensated liver cirrhosis due to metabolic dysfunction-associat…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device. [Phase 3]
A Phase 3 clinical trial (NCT07347275) of DIALIVE 2.0, an extracorporeal liver dialysis device, for acute-on-chronic liver failure and liver…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial [Phase 3]
Phase 3 trial assessing whether aspirin can reduce the risk of hepatocellular carcinoma in patients with liver cirrhosis; the AspiRe HCC Tri…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE) [Phase 2]
Phase 2 clinical trial MASTERPIECE evaluating microbiota transplant therapy for hepatic encephalopathy in cirrhosis; currently not yet recru…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Online Prehabilitation for Patients Awaiting Liver Transplantation [NA]
An online prehabilitation program for patients awaiting liver transplantation is currently recruiting, sponsored by the University of Albert…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Pantoprazole After Prophylactic Endoscopic Variceal Treatment [NA]
A clinical trial is evaluating pantoprazole after prophylactic endoscopic treatment of esophageal and gastric varices in patients with liver…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection [NA]
A clinical trial update describes a vagus nerve-guided laparoscopic splenectomy with azygoportal disconnection for cirrhosis-related hypersp…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis [Phase 2]
A Phase 2 clinical trial evaluating S-adenosyl-L-methionine (SAMe) for prevention of liver cancer in MASLD-related cirrhosis; recruitment no…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Heart Problems in Children With Chronic Liver Disease
Clinical trial update describing a study on heart problems in children with chronic liver disease, currently not yet recruiting, involving c…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Multiparametric Ultrasound for the Noninvasive Diagnosis of Porto-sinusoidal Vascular Liver Disorder [NA]
A clinical trial protocol update evaluating multiparametric ultrasound for noninvasive diagnosis of Porto-sinusoidal vascular liver disorder…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Long-term Efficacy and Safety of LSD Versus TIPS for Cirrhotic Portal Hypertension Bleeding and Hypersplenism [NA]
Clinical trial update describing a planned comparison of LSD versus TIPS for cirrhotic portal hypertension with bleeding and hypersplenism; …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: EUS Elastography for Predicting Cirrhotic-related Complications
An ongoing clinical trial evaluating endoscopic ultrasound elastography to predict cirrhosis-related complications; the study is currently a…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study [NA]
A multicenter randomized controlled trial evaluating whether Fufang Biejiaruangan plus antiviral therapy reduces hepatocellular carcinoma in…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal Bleeding
A clinical trial investigating whether physiological parameters can predict prognosis in patients with liver cirrhosis and gastrointestinal …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment [Phase 1]
A Phase 1 safety evaluation of a mesenchymal stem cell-based therapy for liver cirrhosis; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study [NA]
A prospective pilot study evaluating fiber-optic navigation to guide transjugular intrahepatic portosystemic shunt (TIPS) creation. The stud…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Copper Supplementation in Cirrhosis [NA]
An ongoing University of Washington clinical trial is evaluating copper supplementation in patients with liver disease, including cirrhosis …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis. [NA]
A clinical trial comparing carvedilol plus midodrine versus carvedilol alone to prevent early rebleed in patients with liver cirrhosis; the …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
This clinical trial is investigating host risk factors for invasive pulmonary aspergillosis in patients with liver cirrhosis, aiming to unde…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis
This clinical trial update analyzes the efficacy and survival prediction of transjugular intrahepatic portosystemic shunt (TIPS) in patients…